samedan logo

 
 
spacer
home > pmps > Autumn 2017
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Autumn 2017

   
Text
PDF
Industry Insight 
Industry Insight

PMPS Industry Advisor, Robert Harris, claims that pharma manufacturing processes are steadfast due to a fear of adopting alternative technologies. He also highlights a number of articles in this edition that focus on this.
 
view
download pdf
bullet
Manufacturing
Continuous vs Batch Manufacturing

Making the Switch


EU Automation’s Jonathan Wilkins discusses the downfalls of transitioning from batch to continuous manufacturing, but also suggests that a number of benefits outweigh these.
 
view
download pdf
Developing Continuous Manufacturing

Levelling Up


Malvern Panalytical’s Alon Vaisman and Martin Warman Consultancy’s Martin Warman examine the equipment required to implement continuous manufacturing processes.
 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Controlled Temperature Transport

Reduce, Reuse, Recycle


Pharma laboratories are seeking more efficient packaging solutions to keep on top of the rising volume of regulations, explains Yann Martin at EMBALL'ISO Group.



 
view
download pdf
bullet
Drug Delivery 
Respiratory, Nasal and Injectable Technologies

Cross-Over Tech


Aptar Pharma’s Dr Gerallt Williams recommends that the industry looks to drug delivery areas such as injectables and nasal delivery devices for solutions when faced with respiratory technology challenges.
 
view
download pdf
bullet
STERILE MANUFACTURING
Clean Room Considerations

Sterilisation Steels


Stainless steel has many hygenic qualities, but the various grades offer different benefits. Which grades are the most appropriate for particular scenarios? Sue Springett at Teknomek answers.
 
view
download pdf
bullet
RFID & ANTICOUNTERFEITING
RFID Labelling for Trials

High Demands


Faubel’s Anthony Morrow highlights the benefits of radio-frequency identification technology implementation within labelling to create stronger clinical trial supply chains.
 
view
download pdf
bullet
REVIEW
Event Review

Inspiring Innovation


The PPMA Show returned this year at Birmingham’s NEC between 26-28 September, bringing many industry experts together to discuss and learn more about processing and packaging machinery.
 
view
download pdf
bullet
PACKING & PACKAGING
Child-Resistant Packaging

Looking After Little Ones

Origin Pharma Packaging’s Richard Quelch
outlines the difference between child-resistant and child-proof packaging, analysing the regulations in place that ensure child-proofing standards are maintained.
 
view
download pdf
The Potential of Packaging

More than Boxes and Bottles
 
Patient nonadherence can be linked to poor packaging. Oliver Pittock at Valley Northern investigates the current state of compliance and how it can be guaranteed through industry standards.
 
view
download pdf
bullet
the end of the line
In this edition, ICT Editor Dr Graham Hughes offers PMPS insight on the ramifications of the new EU regulations that are cracking down on counterfeit medications.  
view
download pdf
bullet
PATIENT COMPLIANCE
Q&A: Packaging Adherence

Convenience, Compliance and Cartons


PMPS discusses compliance and packaging-related concerns with August Faller Group’s Dr Daniel Keesman, in light of the company’s win at Pharmapack 2017.
 
view
download pdf
Pills, Deterrence and Compliance

Smart Systems


Dr Neil D Theise and Randice Altschul at Pop Test, Dr Razvan Ene at Elco Group and Dr Mark A Prendergast at the University of Kentucky examine the potential of a ‘smart pill’.
 
view
download pdf
bullet
ROBOTICS & AUTOMATION
Industry 4.0

Pharma’s Digital Journey


Industry 4.0 focuses on digitalisation, which will enhance productivity, competitiveness and business value. Alwyn Jones at Siemens UK & Ireland explores this further.
 
view
download pdf
Highly Potent Products
Developing Highly Potent APIs

Handling Hazards


Aptuit’s Carla Brandolini, Jean-Francois Carniaux, Mario Maio and Iain Rusling weigh up the best practices companies can adopt when developing highly potent active pharmaceutical ingredients.
 
view
download pdf
The REACH Regulation

Supervising Substances


Meeting REACH’s standards has been a considerable hurdle for companies. While aiming to protect people from hazardous chemicals, its extensive rules and regulations complicate procedures, claims Farmak’s Jana Osičková.
 
view
download pdf
bullet
Anti-Counterfeiting and Serialisation
DSCSA Enforcement Delay

What Now?

Justin Schroeder at PCI Pharma Services states that, while it has jumpstarted serialisation practices, the implementation of the FDA’s DSCSA is often delayed due to gaps in the legislation.
 
view
download pdf
Serialisation Software Validation

Redefining Processes


Automating serialisation software validation processes has become ever more crucial due to the constant changes in the market and regulations, as Dan Walles and Lisa Reinhold at TraceLink point out.
 
view
download pdf
 
   

spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
More info >>

White Papers

Cleaning Validation: What do you need to consider to ensure a successful outcome?

RSSL

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support. The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues. So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement